Hassler Melanie R, Pulverer Walter, Lakshminarasimhan Ranjani, Redl Elisa, Hacker Julia, Garland Gavin D, Merkel Olaf, Schiefer Ana-Iris, Simonitsch-Klupp Ingrid, Kenner Lukas, Weisenberger Daniel J, Weinhaeusel Andreas, Turner Suzanne D, Egger Gerda
Clinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Health & Environment Department, Molecular Diagnostics, Austrian Institute of Technology (AIT), 1190 Vienna, Austria.
Cell Rep. 2016 Oct 4;17(2):596-608. doi: 10.1016/j.celrep.2016.09.018.
Aberrant DNA methylation patterns in malignant cells allow insight into tumor evolution and development and can be used for disease classification. Here, we describe the genome-wide DNA methylation signatures of NPM-ALK-positive (ALK+) and NPM-ALK-negative (ALK-) anaplastic large-cell lymphoma (ALCL). We find that ALK+ and ALK- ALCL share common DNA methylation changes for genes involved in T cell differentiation and immune response, including TCR and CTLA-4, without an ALK-specific impact on tumor DNA methylation in gene promoters. Furthermore, we uncover a close relationship between global ALCL DNA methylation patterns and those in distinct thymic developmental stages and observe tumor-specific DNA hypomethylation in regulatory regions that are enriched for conserved transcription factor binding motifs such as AP1. Our results indicate similarity between ALCL tumor cells and thymic T cell subsets and a direct relationship between ALCL oncogenic signaling and DNA methylation through transcription factor induction and occupancy.
恶性细胞中异常的DNA甲基化模式有助于深入了解肿瘤的进化和发展,并可用于疾病分类。在此,我们描述了NPM-ALK阳性(ALK+)和NPM-ALK阴性(ALK-)间变性大细胞淋巴瘤(ALCL)的全基因组DNA甲基化特征。我们发现,ALK+和ALK- ALCL在参与T细胞分化和免疫反应的基因(包括TCR和CTLA-4)上具有共同的DNA甲基化变化,而ALK对基因启动子中的肿瘤DNA甲基化没有特异性影响。此外,我们发现ALCL的整体DNA甲基化模式与不同胸腺发育阶段的模式密切相关,并在富含AP1等保守转录因子结合基序的调控区域观察到肿瘤特异性DNA低甲基化。我们的结果表明ALCL肿瘤细胞与胸腺T细胞亚群之间存在相似性,并且ALCL致癌信号与通过转录因子诱导和占据的DNA甲基化之间存在直接关系。